Putnam Investments’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-57,200
| Closed | -$9.24M | – | 837 |
|
|
2021
Q2 | $9.24M | Buy |
57,200
+23,344
| +69% | +$3.77M | 0.01% | 388 |
|
|
2021
Q1 | $5.8M | Sell |
33,856
-1,077
| -3% | -$184K | 0.01% | 470 |
|
|
2020
Q4 | $7.67M | Sell |
34,933
-1,258
| -3% | -$276K | 0.01% | 420 |
|
|
2020
Q3 | $6.01M | Sell |
36,191
-41
| -0.1% | -$6.81K | 0.01% | 443 |
|
|
2020
Q2 | $4.14M | Sell |
36,232
-149,054
| -80% | -$17M | 0.01% | 507 |
|
|
2020
Q1 | $14.2M | Buy |
185,286
+151,115
| +442% | +$11.6M | 0.04% | 263 |
|
|
2019
Q4 | $4.4M | Sell |
34,171
-43,386
| -56% | -$5.59M | 0.01% | 539 |
|
|
2019
Q3 | $6.04M | Buy |
77,557
+21,197
| +38% | +$1.65M | 0.01% | 470 |
|
|
2019
Q2 | $5.81M | Sell |
56,360
-95,451
| -63% | -$9.83M | 0.01% | 483 |
|
|
2019
Q1 | $11.1M | Sell |
151,811
-284,688
| -65% | -$20.9M | 0.03% | 334 |
|
|
2018
Q4 | $18.5M | Buy |
436,499
+382,051
| +702% | +$16.2M | 0.05% | 234 |
|
|
2018
Q3 | $2.56M | Buy |
54,448
+31,490
| +137% | +$1.48M | 0.01% | 718 |
|
|
2018
Q2 | $1.13M | Sell |
22,958
-670,609
| -97% | -$33M | ﹤0.01% | 831 |
|
|
2018
Q1 | $21.3M | Sell |
693,567
-246,041
| -26% | -$7.55M | 0.05% | 256 |
|
|
2017
Q4 | $17.1M | Buy |
+939,608
| New | +$17.1M | 0.04% | 297 |
|